Cns Pharmaceuticals Inc’s filing revealed that its Director Gumulka Jerzy acquired Company’s shares for reported $10000.0 on Feb 01 ’24. In the deal valued at $0.30 per share,33,333 shares were bought. As a result of this transaction, Gumulka Jerzy now holds 43,006 shares worth roughly $4730.66.
Then, Evans Carl Anthony bought 33,333 shares, generating $10,000 in total proceeds. Upon buying the shares at $0.30, the Director now owns 33,458 shares.
Before that, Downs Christopher bought 66,666 shares. Cns Pharmaceuticals Inc shares valued at $20,000 were divested by the Chief Financial Officer at a price of $0.30 per share. As a result of the transaction, Downs Christopher now holds 103,438 shares, worth roughly $11378.18.
Ladenburg Thalmann downgraded its Cns Pharmaceuticals Inc [CNSP] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating.
Price Performance Review of CNSP
On Tuesday, Cns Pharmaceuticals Inc [NASDAQ:CNSP] saw its stock fall -8.29% to $0.11. Over the last five days, the stock has lost -9.68%. Cns Pharmaceuticals Inc shares have fallen nearly -10.88% since the year began. Nevertheless, the stocks have fallen -99.79% over the past one year. While a 52-week high of $46.75 was reached on 01/06/25, a 52-week low of $0.10 was recorded on 01/14/25. SMA at 50 days reached $0.1137, while 200 days put it at $3.0817.
Levels Of Support And Resistance For CNSP Stock
The 24-hour chart illustrates a support level at 0.1029, which if violated will result in even more drops to 0.0984. On the upside, there is a resistance level at 0.1119. A further resistance level may holdings at 0.1164. The Relative Strength Index (RSI) on the 14-day chart is 43.66, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0007, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 88.50%. Stochastics %K at 22.26% indicates the stock is a holding.
How much short interest is there in Cns Pharmaceuticals Inc?
A steep rise in short interest was recorded in Cns Pharmaceuticals Inc stocks on 2024-10-31, growing by 0.46 million shares to a total of 1.14 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 0.68 million shares. There was a rise of 40.32%, which implies that there is a positive sentiment for the stock.
